UM

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
Hydroxyurea Facilitates Manifestation of Disease Relevant Phenotypes in Patients-Derived IPSCs-Based Modeling of Late-Onset Parkinson’s Disease Journal article
Yuan Tan, Minjing Ke, Zhijian Huang, Cheong-Meng Chong, Xiaotong Cen, Jia-Hong Lu, Xiaoli Yao, Dajiang Qin, Huanxing Su. Hydroxyurea Facilitates Manifestation of Disease Relevant Phenotypes in Patients-Derived IPSCs-Based Modeling of Late-Onset Parkinson’s Disease[J]. Aging and Disease, 2019, 10(5), 1037-1048.
Authors:  Yuan Tan;  Minjing Ke;  Zhijian Huang;  Cheong-Meng Chong;  Xiaotong Cen; et al.
Favorite | TC[WOS]:8 TC[Scopus]:8  IF:7.0/7.1 | Submit date:2020/04/08
Disease Phenotypes  Er Stress  Induced Pluripotentstem Cells  Parkinson’s Disease  Hydroxyurea  
A phase II study of hydroxyurea combined with gemcitabine in patients with head and neck squamous carcinoma and gene expression profiles correlated to poor response Journal article
Zhang K., Kim C., Wu X., Loera S., Wang Y., Chu P., Lim D., Shibata S., Yen Y.. A phase II study of hydroxyurea combined with gemcitabine in patients with head and neck squamous carcinoma and gene expression profiles correlated to poor response[J]. Head and Neck Oncology, 2013, 5(3).
Authors:  Zhang K.;  Kim C.;  Wu X.;  Loera S.;  Wang Y.; et al.
Favorite |  | Submit date:2019/01/16
Gene expression profile  Head and neck squamous cell carcinoma (HNSCC)  Hydroxyurea and gemcitabine